Table 3.

Attributable Fraction and Attributable Incidence of Shigella by Age Group in The Gambia Site for the Global Enterics Multicenter Study and Vaccine Impact on Diarrhea in Africa Study Based on Detection by Quantitative Polymerase Chain Reaction (TaqMan)

Age GroupVIDA (2015–2018)GEMS (2008–2012)
AF (95% CI)AI (95% CI)AF (95% CI)AI (95% CI)
0–11 mo14.02 (9.3–17.1)3.37 (2.3–4.1)7.5 (3.9–12.9)1.0 (.5–1.8)
12–23 mo39.96 (36.5–46.28.83 (8.1–10.2)32.7 (27.0–42.0)6.5 (5.2–8.3)
24–59 mo34.73 (28.9–40.2)2.1 (1.7–2.4)25.9 (18.5–36.1)0.7 (.5–1.1)
Age GroupVIDA (2015–2018)GEMS (2008–2012)
AF (95% CI)AI (95% CI)AF (95% CI)AI (95% CI)
0–11 mo14.02 (9.3–17.1)3.37 (2.3–4.1)7.5 (3.9–12.9)1.0 (.5–1.8)
12–23 mo39.96 (36.5–46.28.83 (8.1–10.2)32.7 (27.0–42.0)6.5 (5.2–8.3)
24–59 mo34.73 (28.9–40.2)2.1 (1.7–2.4)25.9 (18.5–36.1)0.7 (.5–1.1)

Sources: Kotloff et al [3, 4].

Abbreviations: AF, attributable fraction; AI, attributable incidence per 100 child-years; CI, confidence interval; GEMS, Global Enterics Multicenter Study; VIDA, Vaccine Impact on Diarrhea in Africa.

Table 3.

Attributable Fraction and Attributable Incidence of Shigella by Age Group in The Gambia Site for the Global Enterics Multicenter Study and Vaccine Impact on Diarrhea in Africa Study Based on Detection by Quantitative Polymerase Chain Reaction (TaqMan)

Age GroupVIDA (2015–2018)GEMS (2008–2012)
AF (95% CI)AI (95% CI)AF (95% CI)AI (95% CI)
0–11 mo14.02 (9.3–17.1)3.37 (2.3–4.1)7.5 (3.9–12.9)1.0 (.5–1.8)
12–23 mo39.96 (36.5–46.28.83 (8.1–10.2)32.7 (27.0–42.0)6.5 (5.2–8.3)
24–59 mo34.73 (28.9–40.2)2.1 (1.7–2.4)25.9 (18.5–36.1)0.7 (.5–1.1)
Age GroupVIDA (2015–2018)GEMS (2008–2012)
AF (95% CI)AI (95% CI)AF (95% CI)AI (95% CI)
0–11 mo14.02 (9.3–17.1)3.37 (2.3–4.1)7.5 (3.9–12.9)1.0 (.5–1.8)
12–23 mo39.96 (36.5–46.28.83 (8.1–10.2)32.7 (27.0–42.0)6.5 (5.2–8.3)
24–59 mo34.73 (28.9–40.2)2.1 (1.7–2.4)25.9 (18.5–36.1)0.7 (.5–1.1)

Sources: Kotloff et al [3, 4].

Abbreviations: AF, attributable fraction; AI, attributable incidence per 100 child-years; CI, confidence interval; GEMS, Global Enterics Multicenter Study; VIDA, Vaccine Impact on Diarrhea in Africa.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close